1. Home
  2. BOLD vs USEG Comparison

BOLD vs USEG Comparison

Compare BOLD & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • USEG
  • Stock Information
  • Founded
  • BOLD 2018
  • USEG 1966
  • Country
  • BOLD United States
  • USEG United States
  • Employees
  • BOLD N/A
  • USEG N/A
  • Industry
  • BOLD
  • USEG Oil & Gas Production
  • Sector
  • BOLD
  • USEG Energy
  • Exchange
  • BOLD Nasdaq
  • USEG Nasdaq
  • Market Cap
  • BOLD 54.9M
  • USEG 45.0M
  • IPO Year
  • BOLD 2024
  • USEG N/A
  • Fundamental
  • Price
  • BOLD $2.65
  • USEG $1.54
  • Analyst Decision
  • BOLD Buy
  • USEG Strong Buy
  • Analyst Count
  • BOLD 3
  • USEG 2
  • Target Price
  • BOLD $22.50
  • USEG $2.00
  • AVG Volume (30 Days)
  • BOLD 143.3K
  • USEG 58.2K
  • Earning Date
  • BOLD 11-07-2024
  • USEG 11-12-2024
  • Dividend Yield
  • BOLD N/A
  • USEG N/A
  • EPS Growth
  • BOLD N/A
  • USEG N/A
  • EPS
  • BOLD N/A
  • USEG N/A
  • Revenue
  • BOLD N/A
  • USEG $22,257,000.00
  • Revenue This Year
  • BOLD N/A
  • USEG N/A
  • Revenue Next Year
  • BOLD N/A
  • USEG $10.11
  • P/E Ratio
  • BOLD N/A
  • USEG N/A
  • Revenue Growth
  • BOLD N/A
  • USEG N/A
  • 52 Week Low
  • BOLD $2.33
  • USEG $0.81
  • 52 Week High
  • BOLD $15.24
  • USEG $1.91
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • USEG 46.57
  • Support Level
  • BOLD N/A
  • USEG $1.41
  • Resistance Level
  • BOLD N/A
  • USEG $1.61
  • Average True Range (ATR)
  • BOLD 0.00
  • USEG 0.11
  • MACD
  • BOLD 0.00
  • USEG -0.02
  • Stochastic Oscillator
  • BOLD 0.00
  • USEG 35.14

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business activities in South Texas and the Williston Basin in North Dakota. The company generates revenue from its interest in the sales of oil and natural gas production.

Share on Social Networks: